Pascolo S, Bervas N, Ure J M, Smith A G, Lemonnier F A, Pérarnau B
Institut Pasteur, Département SIDA-Rétrovirus, Unité d'Immunité Cellulaire Antivirale, 75724 Paris Cedex 15, France.
J Exp Med. 1997 Jun 16;185(12):2043-51. doi: 10.1084/jem.185.12.2043.
Three different HLA-A2.1 monochains were engineered in which either the human or mouse beta2-microglobulin (beta2m) is covalently linked to the NH2 terminus of the heavy chain by a 15- amino acid long peptide: HHH, entirely human, HHD, with the mouse H-2Db alpha3, transmembrane, and cytoplasmic domains, and MHD, homologous to HHD but linked to the mouse beta2mb. The cell surface expression and immunological capacities of the three monochains were compared with transfected cells, and the selected HHD construct was introduced by transgenesis in H-2Db-/- beta2m-/- double knockout mice. Expression of this monochain restores a sizable peripheral CD8(+) T cell repertoire essentially educated on the transgenic human molecule. Consequently, infected HHD, H-2Db-/- beta2m-/- mice generate only HLA-A2.1-restricted CD8(+) CTL responses against influenza A and vaccinia viruses. Interestingly, the CTL response to influenza A virus is mostly, if not exclusively, directed to the 58-66 matrix peptide which is the HLA-A2.1-restricted immunodominant epitope in humans. Such mice might constitute a versatile animal model for the study of HLA-A2.1-restricted CTL responses of vaccine interest.
构建了三种不同的HLA-A2.1单链,其中人或小鼠的β2-微球蛋白(β2m)通过一个15个氨基酸长的肽共价连接到重链的NH2末端:完全人源的HHH、带有小鼠H-2Db α3、跨膜和胞质结构域的HHD,以及与HHD同源但与小鼠β2m相连的MHD。将这三种单链的细胞表面表达和免疫能力与转染细胞进行了比较,并通过转基因将选定的HHD构建体导入H-2Db-/-β2m-/-双敲除小鼠中。这种单链的表达恢复了相当数量的外周CD8(+) T细胞库,这些细胞基本上是在转基因人类分子上接受教育的。因此,感染的HHD、H-2Db-/-β2m-/-小鼠仅产生针对甲型流感病毒和痘苗病毒的HLA-A2.1限制性CD8(+) CTL反应。有趣的是,对甲型流感病毒的CTL反应大多(如果不是全部)针对58-66基质肽,这是人类中HLA-A2.1限制性免疫显性表位。此类小鼠可能构成一种通用的动物模型,用于研究具有疫苗研究意义的HLA-A2.1限制性CTL反应。